Overview

D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
D-cycloserine may help lessen pain and other symptoms of peripheral neuropathy caused by chemotherapy. It is not yet known whether D-cycloserine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy. This randomized, double-blind, placebo-controlled clinical trial was designed to study D-cycloserine at 2 different doses to see how well each works compared to the other and to a placebo in treating cancer patients with peripheral neuropathy caused by chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University
Treatments:
Cycloserine